Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

Veracyte

Natera

CareDx

Adaptive Biotechnologies

Guardant Health Inc

Beam Therapeutics

Schrodinger 

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

For all the concerns surrounding tech investments over the last year, with mega-cap tech names like Amazon (AMZN) and Meta (META) being the poster children for the broad market selloff, biotech remains an appealing option.

Get Benefits From Innovator ACCD in Health Tech ETF ARKG

American Airlines

Amplify Online Retail ETF

US Global Jets ETF

Proshares Online Retail ETF

Invesco WilderHill Clean Energy ETF

Wall Street has been showing immense strength to start 2023. These sectors and their ETFs have returned double-digit returns to start 2023.

4 Sectors & Their ETFs Returning Double-Digits to Start 2023

Global X Longevity Thematic ETF 

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

First Trust NYSE Arca Biotechnology Index Fund

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

Amplify Treatments Testing & Advancements ETF

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

iShares Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares Global Healthcare ETF

iShares U.S. Healthcare ETF

Eli Lilly

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Merck

Novo Nordisk

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Simplify Health Care ETF

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P SmallCap Health Care ETF

Invesco DWA Healthcare Momentum ETF

Invesco S&P 500 Equal Weight Health Care ETF

ALPS Medical Breakthroughs ETF

Vanguard Health Care ETF

Wisdomtree BioRevolution Fund

SPDR S&P Biotech ETF

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

There are a lot of reasons to be skeptical of tech investing right now since last year's broad market selloff — just how far is the Fed planning to go with rising rates this year, anyway? Still, there is a place for a smart tech slice in investors' portfolios, especially in companies disrupting and innovating

EXAS Nears Key Buy Signal in Active Biotech ETF ARKG

ARK Genomic Revolution ETF invests in small-cap and mid-cap companies engaged in genomic revolution, i.e., in the research of genomic sequencing, analysis, synthesis, or instrumentation. Alpha-generating stocks ARKG selects from time to time and backs for a longer time period have in general generated strong returns. Sadly, this is not the case this time.

ARKG: Despite A Huge Price Loss In 2022, Not The Right Time To Accumulate

ARK Invest does great deep-dive research. Utilize their insights along with market timing considerations to generate alpha. The performance of ARKG is dictated mostly by interest rate decisions in the current environment. But underneath the macro layer, there are many promising tailwinds germinating in the background.

ARKG: Market May Ridicule ARK, But You Shouldn't Ignore Their Genomics ETF

ARK Innovation ETF

Ready for the new year? It wouldn't be surprising for most ETF investors to be excited to put 2022 in the rear view.

Why Now Could Be Time to Buy No Cap Gain ARK Strats

2022 has been a wild year for markets, from Russia's invasion of Ukraine to the Fed's dedicated rate hike campaign. That hasn't stopped the world from innovating, though, with firms in areas from biotech to cloud computing to robotics and AI working hard on advancements that can change their entire industries.

Top-Read Disruptive Technology Stories of 2022

ARK Industrial Innovation ETF

ARK Web x.0 ETF

ARK Invest and CEO Cathie Wood have once again bought the dip on firms the company believes have long term potential to be real innovators, adding shares from Tesla (TSLA), Coinbase (COIN), and Verve Therapeutics (VERV) on Wednesday.

ARK Continues Contrarian Plays in ETFs TSLA, COIN, VERV

2022 hasn't been a great year for all kinds of tech stocks, and certainly biotech has taken its fair share of lumps as interest rates have continued to dry up funding. That hasn't stopped the innovation that makes biotech such an appealing space, however.

Gene Editing Stock in ARKG Gets Buy Rating

While the headlines have focused on a crypto winter, it hasn't exactly been an easy year for biotech. The sector that blossomed amid a global pandemic has struggled with the pandemic easing and rates rising.

Why a Biotech ETF Might Cure Your Portfolio in 2023

You may have missed it over Thanksgiving week, but there's reason to be excited about at least one biotech firm on the market. Exact Sciences Corp (EXAS) was recently the subject of positive attention from Wall Street analysts, who believe that it could be poised to surge.

Why This Biotech Firm is the Top Weight in ARKG

ARK Invest, which manages $14 billion in ETF assets primarily through active, disruptive technology ETFs, moved headquarters last week to Tampa/St. Petersburg, Florida, from New York. The firm runs some of the more popular active ETFs, including the ARK Innovation ETF (ARKK), the ARK Genomics Revolution (ARKG), and the ARK Next Generation ETF Internet (ARKW).

ARK Completes Move to Florida With Broad Research Team

This week's soft CPI print has sent the stock market into a flurry of positivity, hitting multi-year highs on Thursday as investor optimism leaped forward.

Biotech Earnings, Market Leap Boost ARKG Potential

Telehealth options remain very popular with consumers for routine appointments, according to a recent survey, preferred to in-person options for routine care.

As Flu Season Consumers Prefer Telehealth, Watch ARKG

ARK Genomic Revolution ETF (ARKG) holding Pacific Biosciences (PACB) opened lower on Monday but is still posting one-month returns topping 48%.  Shares of Pacific Biosciences traded up around 16% last Friday after a busy news week.

ARKG Holding PacBio's 1-Month Returns Top 48%

U.S. equities across all sectors are rebounding Thursday following the release of a hotter-than-expected inflation report.  After recent volatility, shares of Senti Biosciences have increased nearly 22% on Thursday, bringing its one-month returns to nearly 72%.

ARKG Holding Senti Biosciences Increases 22% Thursday as Markets Rally

ARK Fintech Innovation ETF

ARK Space Exploration & Innovation ETF

ARK Israel Innovative Technology ETF

The 3D Printing ETF

The ARK Innovation ETF (ARKK) accreted nearly half a billion dollars from investors in September. ARK Invest's flagship fund saw $441 million in net inflows in September, bringing the year-to-date net inflows to $1.4 billion.

ARKK Takes in Nearly Half Billion in September Flows

ARKG's objective is compelling and inoffensive, but their current approach to realizing it feels too vague and scattershot. While the larger names in the portfolio do appear to belong, the bulk of the fund is in up-and-coming names, pre-profit, that feel like acquisition is their next step.

ARKG: Too Hard To Pin Down, Too Volatile For Comfort

In order to realize the full potential of a genomic revolution-themed ETF, like ARKG, investors have to be patient and look for a longer time horizon. ARKG does some effective reshuffling from time to time, which backs some alpha-producing low-priced stocks, and sells out one or two large-cap biotech stocks.

ARKG: A Genomic Revolution Fund For Long Term Growth Seeking Investors

Tesla

Coinbase

Roku

Block

Zoom Video

Cathie Wood's Ark Invest ETFs were some of the hottest ETFs after 2020's huge gains. Five ARK Invest stocks to watch include Tesla.

Ark Invest Stocks To Watch: 5 Stocks That Cathie Wood's ARK ETFs Own; Tesla Slides To Key Level

Last week saw significant volatility. However, positive sentiment intensified throughout the biotech space, propelled by favorable legislation and encouraging trial data.

Positive Sentiment in Biotech Intensifies, Add ARKG

ARK Invest has shaken up the management of its passive ETF offerings by removing CIO Cathie Woods from the day-to-day management of the funds.

ARK Changes Management on Passive ETF Lineup

New advances in synthetic biology uncovers lucrative investment opportunities for advisors.

ARKG Offers Exposure to Advancements in Synthetic Biology

Shares of Signify Health (SGFY) have continued to trade up on rumors of CVS Health Corp's (CVS) interest in acquiring the company. Signify Health is exploring strategic alternatives, including a sale, the Wall Street Journal reported last month.

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)